Germany · Investor

CD-Venture

Filed with the SEC to raise a fund in Oct 2026, closing $1M. Last cheque observed Aug 2025.

QuietNew fund $950K, Oct 2026VC firm

Series BSeries ASeries CLife Science

Cheques on record
0%of best year0cheques in 12 months, 9 on record
Since the last cheque431days00hrs00min00sec
Median round$36MRounds led0 of 9Exits1 from the portfolioMostly inUnited States, 44%
Pitch CD-Venture

CD-Venture highlights

  1. 01

    9 rounds on record

  2. 02

    Mostly Series B and Series A: 63% of its rounds

  3. 03

    1 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
Life Science
Based in
Merrimack, Germany
Cold pitches
Not stated

The record

Every round we can evidence, newest first9 appearances

  1. 2025

    2 rounds

  2. Aug
    WellthSeries C · US · Comcast Ventures$36MWith 8 others
  3. Jan
    Cera CareGB · Firms' own news pages$150MWith 10 others
  4. 2018

    1 round

  5. Nov
    WellthSeries A · US · FinSMEs$5.1MWith 5 others
  6. 2015

    2 rounds

  7. Sept
    Exosome DiagnosticsSeries B · US$18MWith 4 others
  8. Jul
    leon nanodrugsSeries A · DE$20MWith 4 others
  9. 2014

    2 rounds

  10. Nov
    CuretisSeries B · DE$18MWith 6 others
  11. Sept
    Flex PharmaVenture · US$40MWith 9 others
  12. 2013

    1 round

  13. Sept
    GenomeDx BiosciencesSeries B · CA · socaltech.comUndisclosedWith 3 others
  14. 2010

    1 round

  15. Sept
    Phenex PharmaceuticalsSeries C · DE · finsmes.com$7.9MWith 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

Phenex PharmaceuticalsBought by Gilead Sciences$470MJan 2015

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as CD-Venture. A count of rooms they were both in, not a relationship either has claimed.

Aeris CapitalGrowth equity2rounds togetherForbion Capital PartnersPrivate equity2rounds together

Recently backed

The latest companies CD-Venture put money into.

Wellth$36M · Aug 2025

Quick answers about CD-Venture

What does CD-Venture invest in?

CD-Venture invests most often at Series B and Series A (63% of the rounds on record), in sectors such as Life Science.

How active is CD-Venture?

9 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2025.

What has CD-Venture invested in recently?

Its most recent investments on record: Wellth (Series C, Aug 2025) and Cera Care (Jan 2025).

How big are CD-Venture's cheques?

The median round it joins is $36M.

Does CD-Venture lead rounds?

Rarely, if at all: none of its 9 investments on record names it as the lead.

Where does CD-Venture invest?

Most of the companies it backs are in the United States (44%), Germany (33%) and the United Kingdom (11%).

Is CD-Venture investing now?

No investments in the last 12 months; the latest was in Aug 2025.

Who does CD-Venture invest alongside?

Most often Aeris Capital (2 rounds together) and Forbion Capital Partners (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it